Imaging of Cardiac Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis
American Journal of Roentgenology · 2024
DOI: 10.2214/ajr.23.29870 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Roentgenology, 2024. Verfasst von Gauri R Karur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Fibrosis, Cardiomyopathies. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 100 Literaturangaben.
Abstract (Originalsprache)
Myocardial fibrosis (MF) is defined as excessive production and deposition of extra-cellular matrix proteins that result in pathologic myocardial remodeling. Three types of MF have been identified: replacement fibrosis from tissue necrosis, reactive fibrosis from myocardial stress, and infiltrative interstitial fibrosis from progressive deposition of nondegradable material such as amyloid. Although echocardiography, nuclear medicine, and CT play important roles in the assessment of MF, MRI is pivotal in the evaluation of MF, with the late gadolinium enhancement (LGE) technique used as a primary end point. The LGE technique focuses on the pattern and distribution of gadolinium accumulation in the myocardium and assists in the diagnosis and establishment of the cause of both ischemic and nonischemic cardiomyopathy. LGE MRI also aids prognostication and risk stratification. In addition, LGE MRI is used to guide the management of patients considered for ablation for arrhythmias. Parametric mapping techniques, including T1 mapping and extracellular volume measurement, allow detection and quantification of diffuse fibrosis, which may not be detected by LGE MRI. These techniques also allow monitoring of disease progression and therapy response. This review provides an update on the imaging of MF, including prognostication and risk stratification tools, electrophysiologic considerations, and disease monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.
- Joint Department of Medical Imaging, University Medical Imaging Toronto, Toronto General Hospital, Toronto, ON, Canada.
- Department of Cardiology, MetroHealth System, Cleveland, OH.
- Department of Radiology, NYU Langone Medical Center, New York, NY.
- Department of Cardiology, University of Michigan Health, Ann Arbor, MI.
- Department of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany.
Zitieren
APA
Karur, G. R., Aneja, A., Stojanovska, J., Hanneman, K., Latchamsetty, R., Kersting, D., & Rajiah, P. S. (2024). Imaging of Cardiac Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis. American Journal of Roentgenology. https://doi.org/10.2214/ajr.23.29870
Vancouver
Karur GR, Aneja A, Stojanovska J, Hanneman K, Latchamsetty R, Kersting D, et al. Imaging of Cardiac Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis. American Journal of Roentgenology. 2024. doi:10.2214/ajr.23.29870
BibTeX
@article{Karur2024,
author = {Karur, Gauri R and Aneja, Ashish and Stojanovska, Jadranka and Hanneman, Kate and Latchamsetty, Rakesh and Kersting, David and Rajiah, Prabhakar Shantha},
title = {Imaging of Cardiac Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis},
journal = {American Journal of Roentgenology},
year = {2024},
doi = {10.2214/ajr.23.29870}
}
EUVIMED